Familial Mediterranean Fever; Recent Advances, Future Prospectives

Key Findings

• ●JAK inhibitors (tofacitinib) showing promise in case series
• ●Updated pipeline of emerging therapies

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.